Expansion of the Dermatology-Based Skincare Business
First written in FY2016. 19 of 37 entries say "Advanced", first in FY2020. Latest entry: 2026-08-03.
1 other company's latest entry also says "Advanced".
- 2026-08-03AdvancedEarnings
「Sales increased for both the Collage Furfur and Collage Repair brands of basic skincare products.」
Describes progress in expanding the healthcare business through sales growth at 2 brands. - FY2026AdvancedAnnual report
「Healthcare business revenue rose 10.3% from the previous fiscal year to ¥7,908 million. Sales grew for both the Collage Furfur brand, including shampoos and soaps containing antifungal ingredients, and the Collage Repair brand of basic cosmetics.」
Sales growth at both brands drove full-year healthcare business revenue to ¥7,908 million, up 10.3% from the previous fiscal year. - FY2026-H1AdvancedAnnual report
「Healthcare business revenue rose 10.9% year on year to ¥3,926 million. Sales grew for both the Collage Furfur brand, including shampoos and soaps containing antifungal ingredients, and the Collage Repair brand of basic cosmetics.」
Sales grew for both the Collage Furfur and Collage Repair brands, and healthcare business revenue rose 10.9% year on year. - FY2025AdvancedAnnual report
「Healthcare business revenue rose 11.5% from the previous fiscal year to ¥7,169 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Sales growth at the 2 core brands drove healthcare business revenue to ¥7,169 million, up 11.5% from the previous fiscal year. - FY2025-H1AdvancedAnnual report
「Healthcare business revenue rose 11.0% year on year to ¥3,540 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Sales of key skincare and hygiene-related products grew, and healthcare business revenue rose 11.0% year on year to ¥3,540 million. - FY2024AdvancedAnnual report
「Healthcare business revenue rose 8.6% from the previous fiscal year to ¥6,430 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Reports healthcare business revenue of ¥6,430 million, up 8.6% from the previous fiscal year, along with sales growth for key skincare and hygiene-related products. - FY2024-Q3AdvancedAnnual report
「Healthcare business revenue rose 8.8% year on year to ¥5,034 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Reports specific progress for the healthcare business centered on the Collage Furfur Series and Collage Repair Series, with revenue of ¥5,034 million, up 8.8% year on year. - FY2024-Q2AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists, gynecologists, nurses and others, and pursued market development. Healthcare business revenue rose 6.4% year on year to ¥3,190 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Continuing marketing and market development based on support from healthcare professionals, with healthcare business revenue of ¥3,190 million, up 6.4% year on year. - FY2024-Q1AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists, gynecologists, nurses and others, and pursued market development. Healthcare business revenue rose 10.7% year on year to ¥1,607 million. Sales grew for the Collage Furfur Series, including shampoos and soaps containing antifungal ingredients, and the Collage Repair Series of basic cosmetics.」
Continuing marketing and market development based on support from healthcare professionals, with healthcare business revenue of ¥1,607 million, up 10.7% year on year. - FY2023AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists and gynecologists, and pursued market development. Healthcare business revenue rose 3.3% from the previous fiscal year to ¥5,920 million.」
Continuing marketing and market development based on support from physicians, with healthcare business revenue rising 3.3% from the previous fiscal year to ¥5,920 million. - FY2023-Q3AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists and gynecologists, and pursued market development. Healthcare business revenue rose 6.0% year on year to ¥4,626 million. Sales grew for the Collage Furfur Series of shampoos, rinses and soaps containing antifungal ingredients, hair-growth products from the same series, and the Collage Repair Series of basic cosmetics.」
Reports continued marketing and market development based on support from physicians, with healthcare business revenue of ¥4,626 million, up 6.0% year on year, and sales growth for multiple products. - FY2023-Q2AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists and gynecologists, and pursued market development. Healthcare business revenue rose 5.7% year on year to ¥3,000 million. Sales grew for the Collage Furfur Series of shampoos, rinses and soaps containing antifungal ingredients, hair-growth products from the same series, and the Collage Repair Series of basic cosmetics.」
Continuing marketing and market development based on support from physicians, with healthcare business revenue of ¥3,000 million, up 5.7% year on year. - FY2023-Q1AdvancedAnnual report
「The healthcare business has also worked to advance marketing based on strong support from dermatologists and gynecologists, and pursued market development. Healthcare business revenue rose 5.8% year on year to ¥1,452 million. Sales grew for the Collage Furfur Series of shampoos, rinses and soaps containing antifungal ingredients, hair-growth products from the same series, and the Collage Repair Series of basic cosmetics.」
Reports continued marketing and market development based on support from physicians, with healthcare business revenue of ¥1,452 million, up 5.8% year on year, and sales growth for multiple products. - FY2022RestatedAnnual report
「The healthcare business has also operated as a pioneer in skincare for sensitive skin, strengthening its marketing efforts and pursuing market development. Healthcare business revenue rose 0.4% from the previous fiscal year to ¥5,732 million.」
Continuing to strengthen marketing and develop the market, centered on skincare for sensitive skin, with the healthcare business generating higher revenue. - FY2022-Q3AdvancedAnnual report
「The healthcare business has also operated as a pioneer in skincare for sensitive skin, strengthening its marketing efforts and pursuing market development. Healthcare business revenue rose 0.5% year on year to ¥4,363 million. Sales grew for the Collage Furfur Series of shampoos, rinses and soaps containing antifungal ingredients, hair-growth products from the same series, and the Collage Repair Series of basic cosmetics.」
Reports continued marketing and market development, with healthcare business revenue of ¥4,363 million, up 0.5% year on year. Sales also grew for multiple skincare and hygiene-related products. - FY2022-Q2AdvancedAnnual report
「The healthcare business has also operated as a pioneer in skincare for sensitive skin, strengthening its marketing efforts and pursuing market development. Healthcare business revenue rose 2.3% year on year to ¥2,839 million. Sales grew for the Collage Furfur Series of shampoos and rinses containing antifungal ingredients, hair-growth products from the same series, and the Collage Repair Series of basic cosmetics.」
Continuing to strengthen marketing and develop the market, with healthcare business revenue rising 2.3% year on year to ¥2,839 million. - FY2022-Q1RestatedAnnual report
「The healthcare business has also operated as a pioneer in skincare for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing to strengthen marketing and develop the market, centered on skincare for sensitive skin. Healthcare business revenue rose 0.7% year on year to ¥1,372 million. - FY2021AdvancedAnnual report
「Sales of the Collage Furfur Series, including shampoos, rinses and soaps containing antifungal ingredients, remained firm, and healthcare business revenue rose 7.3% from the previous fiscal year to ¥5,709 million.」
Reports specific full-year progress for the healthcare business centered on the Collage Furfur Series, with revenue of ¥5,709 million, up 7.3% from the previous fiscal year. - FY2021-Q3AdvancedAnnual report
「Demand for hygiene-related products such as cleansing soap remained strong due to the effects of COVID-19. Against this business backdrop, sales of the Collage Furfur Series, including shampoos, rinses and soaps containing antifungal ingredients, remained firm, and healthcare business revenue rose 6.6% year on year to ¥4,342 million.」
Reports specific progress for the healthcare business centered on the Collage Furfur Series, with revenue of ¥4,342 million for the nine months ended the third quarter, up 6.6% year on year. - FY2021-Q2AdvancedAnnual report
「Demand for hygiene-related products such as cleansing soap remained strong due to the effects of COVID-19. Against this business backdrop, sales of the Collage Furfur Series, including shampoos, rinses and soaps containing antifungal ingredients, remained firm, and healthcare business revenue rose 1.1% year on year to ¥2,774 million.」
Healthcare business revenue rose 1.1% year on year, driven by increased demand for hygiene-related products due to COVID-19. - FY2021-Q1RestatedAnnual report
「The cosmetics market remained sluggish due to requests to refrain from going out and other effects of COVID-19, while demand for hygiene-related products such as cleansing soap increased. Against this business backdrop, sales of the Collage Furfur Series, including shampoos, rinses and soaps containing antifungal ingredients, remained firm, and healthcare business revenue rose 9.6% year on year to ¥1,362 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series despite changes in market conditions caused by COVID-19, with revenue up 9.6% year on year. - FY2020AdvancedAnnual report
「Against this business backdrop, sales of the Collage Furfur Series, including shampoos and rinses containing antifungal ingredients, remained firm, and healthcare business revenue rose 6.8% from the previous fiscal year to ¥5,322 million.」
Healthcare business revenue rose 6.8% from the previous fiscal year to ¥5,322 million amid intensifying competition. - FY2020-Q3RestatedAnnual report
「Although the market is growing, competition is intensifying. Against this backdrop, sales of the Collage Furfur Series, including shampoos and rinses containing antifungal ingredients, remained firm, and healthcare business revenue rose 5.4% year on year to ¥4,075 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series amid intensifying competition, with revenue for the nine months ended the third quarter up 5.4% year on year. - FY2020-Q2RestatedAnnual report
「Although the market is growing, competition is intensifying. Against this backdrop, sales of the Collage Furfur Series, including shampoos and rinses containing antifungal ingredients, remained firm, and healthcare business revenue rose 10.2% year on year to ¥2,743 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series amid intensifying competition. Revenue for the six months ended the second quarter rose 10.2% year on year. - FY2020-Q1RestatedAnnual report
「The healthcare business has also operated as a pioneer in skincare for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing to strengthen marketing and develop the market, centered on skincare for sensitive skin. Healthcare business revenue rose 8.6% year on year to ¥1,243 million. - FY2019RestatedAnnual report
「The healthcare business has also operated as an expert in basic cosmetics for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing to strengthen marketing and develop the market, centered on basic cosmetics for sensitive skin. - FY2019-Q3RestatedAnnual report
「Although the market is growing, competition is intensifying. Against this backdrop, sales of the Collage Furfur Series, including shampoos and rinses containing antifungal ingredients, remained firm, and healthcare business revenue rose 5.8% year on year to ¥3,867 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series amid intensifying competition, with revenue up 5.8% year on year. - FY2019-Q2RestatedAnnual report
「Although the market is growing, competition is intensifying. Against this backdrop, sales of the Collage Furfur Series, including shampoos and rinses containing antifungal ingredients, remained firm, and healthcare business revenue rose 7.3% year on year to ¥2,489 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series amid intensifying competition, with revenue for the six months ended the second quarter up 7.3% year on year. - FY2019-Q1RestatedAnnual report
「The healthcare business has also operated as an expert in basic cosmetics for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing to strengthen marketing and develop the market, centered on basic cosmetics for sensitive skin. Healthcare business revenue declined 1.2% year on year in the first quarter. - FY2018RestatedAnnual report
「Although the market is growing moderately, the Collage Furfur Series of products including shampoos and rinses containing antifungal ingredients remained firm amid intensifying competition. Revenue rose 5.8% from the previous fiscal year to ¥4,738 million.」
Continuing to develop the healthcare market centered on the Collage Furfur Series amid intensifying competition. - FY2018-Q3RestatedAnnual report
「Although the market is growing moderately, the Collage Furfur Series of products including shampoos and rinses containing antifungal ingredients remained firm amid intensifying competition. Revenue rose 5.1% year on year to ¥3,653 million.」
Continuing to expand the healthcare business centered on the Collage Furfur Series despite intensifying competition. - FY2018-Q2RestatedAnnual report
「Against a backdrop of slowing market growth and intensifying competition, the Collage Furfur Series of products including shampoos and rinses containing antifungal ingredients remained firm. Revenue rose 3.8% year on year to ¥2,319 million.」
The healthcare business centered on the Collage Furfur Series continues to expand amid slowing market growth and intensifying competition. - FY2018-Q1RestatedAnnual report
「Against a backdrop of slowing market growth and intensifying competition, the Collage Furfur Series of products including shampoos and rinses containing antifungal ingredients remained firm. Revenue rose 8.7% year on year to ¥1,158 million.」
Continuing to develop the market for the healthcare business centered on the Collage Furfur Series amid slowing market growth and intensifying competition. - FY2017-Q3RestatedAnnual report
「Against a backdrop of slowing market growth and intensifying competition, the Collage Furfur Series of antimicrobial care products, including shampoos and rinses containing antifungal agents, remained firm. Revenue rose 8.7% year on year to ¥3,476 million.」
Continuing to expand the healthcare business centered on the Collage Furfur Series amid slowing market growth and intensifying competition. - FY2017-Q2RestatedAnnual report
「The healthcare business has also operated as an expert in basic cosmetics for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing to strengthen marketing and develop the market, centered on basic cosmetics for sensitive skin. - FY2017-Q1RestatedAnnual report
「The healthcare business has also operated as an expert in basic cosmetics for sensitive skin, strengthening its marketing efforts and pursuing market development.」
Continuing initiatives to strengthen marketing and develop the market in the healthcare business. - FY2016First statedAnnual report
「We will continue to strengthen our collaboration with dermatologists and provide low-irritation, highly functional skincare products based on dermatological science. We will expand sales of products such as the Collage Furfur Series, establish the brand, and pursue further market development.」
Described as a means of developing the market and establishing the brand for the healthcare business.